What is the success rate of CyberKnife for prostate cancer?
Results from the study showed that intermediate-risk prostate cancer patients treated with CyberKnife had a disease-free survival rate of 97.1 percent five years after treatment. For low-risk prostate cancer patients treated with CyberKnife, the five-year disease-free survival rate was 97.3 percent.
How does CyberKnife work on prostate cancer?
The CyberKnife robot, guided by motion synchronization software, can deliver radiation from virtually any angle — allowing it to maintain sub-millimeter accuracy throughout treatment delivery. Greater precision helps minimize dose to surrounding healthy tissues, reducing the risk of many common side effects.
What is the difference between radiation and CyberKnife for prostate cancer?
Cyberknife Is More Accurate Than Traditional Radiation Therapy. Because it's able to target diseased tissue, Cyberknife SBRT is much more accurate than traditional radiation therapy. SBRT can deliver radiation to a margin of one to five millimeters surrounding a tumor.
Who is a candidate for CyberKnife for prostate cancer?
Who is a Candidate for Treatment? Cyberknife is typically used for patients with: Early-stage disease. Localized disease (confined to the prostate).
What are some disadvantages of the CyberKnife?
Potential side effects of CyberKnife® treatment for lung cancerFatigue.Breathing difficulties.Cough.Hemoptysis (coughing up blood)Radiation pneumonitis.Radiation fibrosis.Complications (such as pneumothorax) resulting from fiducial marker insertion.Exposure to airways and/or nearby tissue.
How do you feel after CyberKnife?
After treatment and follow-up There are minimal side effects from CyberKnife treatment. The most common side effect is fatigue. Most of the time, patients are able to go back to their usual activities but will need someone to drive them home immediately after treatment.
Can prostate cancer come back after CyberKnife?
The two major types of prostate cancer recurrence that can be treated using CyberKnife are local and distant. Prostate cancer recurrences in the tissue surrounding the prostate, such as in the seminal vesicles, pelvic floor muscles or rectum, are known as local recurrences.
Who is a candidate for CyberKnife?
Who is a candidate for CyberKnife? CyberKnife can be used as a first-line treatment for early-stage prostate cancer. It can be combined with hormone therapy for cancer that has spread into nearby tissues. It can also be used to slow progression in advanced cancer or cancer that has recurred after previous treatment.
What is the success rate of CyberKnife?
As a primary treatment Cyberknife can achieve a local control of nearly 90% in patients with a median follow up of 18 months. Radicular pain has been relieved in 25–85% of patients and neurological deficits improved to a lesser degree.
Is CyberKnife better than surgery?
In many clinical situations, CyberKnife has local control and effectiveness that is equivalent to surgery. However, due to its non-invasive nature, the risk of side effects is significantly lower with CyberKnife. 2. Real-time tumor tracking results in less radiation to the nearby normal tissues.
How do I prepare for CyberKnife?
PREPARING FOR TREATMENT Prior to CyberKnife treatment, you will undergo a CT scan, which helps determine the exact size, shape and location of the prostate. An MRI scan also may be necessary to fully visualize the prostate and nearby anatomy.
What is the best option for prostate cancer?
Radiation therapy is a good choice for many men with early-stage prostate cancer. It is also the best treatment for older men or those who have other health problems. There are different types of radiation therapy: External beam radiation.